Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 18, 2019 Off

Novocure to Participate in Oppenheimer’s 29th Annual Healthcare Conference

By BusinessWire

ST. HELIER, Jersey–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24NVCR&src=ctag" target="_blank"gt;$NVCRlt;/agt;–Novocure (NASDAQ:NVCR) announced today that Wilco Groenhuysen, Novocure’s Chief Financial Officer, will participate in Oppenheimer’s…

March 18, 2019 Off

Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results

By BusinessWire

First Subjects Dosed in Phase I Clinical Trial for Lead Autoimmune/Inflammatory Disease Program, ALPN-101 Completed $25 Million Private Placement Strong…

March 18, 2019 Off

Enanta Pharmaceuticals Completes Enrollment in Two Ongoing Phase 2 Studies

By BusinessWire

Respiratory Syncytial Virus (RSV) Human Challenge Study with EDP-938 ARGON-1 Study in Non-alcoholic Steatohepatitis (NASH) with EDP-305 WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a…

March 18, 2019 Off

IMV and Centre de Recherche du CHU de Québec-Université Laval Collaboration Awarded a CQDM Grant to Develop First-in-Class Dual Target T Cell Therapy in Bladder Cancer Based on IMV’s DPX Technology

By BusinessWire

QUEBEC CITY, Quebec–(BUSINESS WIRE)–IMV Inc. (IMV) (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Canadian bioresearch…

March 18, 2019 Off

Kit Check™ and Avery Dennison Partner to Improve Patient Safety by Integrating RFID into cGMP Packaging Lines

By BusinessWire

RFID technology improves accuracy and visibility of the medication supply chain, from the production line to the patient WASHINGTON–(BUSINESS WIRE)–Kit…

March 18, 2019 Off

Imara Closes a $63MM Series B Cross-Over Financing

By BusinessWire

-Proceeds to Advance IMR-687 for the Treatment of Sickle Cell Disease (SCD) and Thalassemia, and Expand Company Pipeline -New Investors:…

March 18, 2019 Off

Impella RP Post-Approval Study Data Presented at ACC 2019

By BusinessWire

Data demonstrates survival benefit with the Impella RP Recover Right protocol NEW ORLEANS, La.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/heartrecovery?src=hash" target="_blank"gt;#heartrecoverylt;/agt;–Abiomed (NASDAQ:ABMD), a leading…

March 18, 2019 Off

Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy

By BusinessWire

TIME-2b Study Did Not Meet the Primary Endpoint of 2-Step Reduction in DRSS Score Conference Call and Webcast Today, March…

March 18, 2019 Off

Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…

March 18, 2019 Off

Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…

Posts pagination

Previous 1 … 3,351 3,352 3,353 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine